Page last updated: 2024-08-23

oxcarbazepine and caffeine

oxcarbazepine has been researched along with caffeine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Beckmann, H; Berger, W; Deckert, J; Heckers, S; Heinsen, H; Kleopa, K; Ransmayr, G; Riederer, P1
Bošković, B; Prostran, MŠ; Stepanović-Petrović, RM; Tomić, MA; Ugrešić, N; Vučković, SM2
Fredholm, BB; Reid, AR; Sawynok, J1

Reviews

1 review(s) available for oxcarbazepine and caffeine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for oxcarbazepine and caffeine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Adenosine A1 receptors in human hippocampus: inhibition of [3H]8-cyclopentyl-1,3-dipropylxanthine binding by antagonist drugs.
    Neuroscience letters, 1993, Feb-19, Volume: 150, Issue:2

    Topics: Aged; Anticonvulsants; Autoradiography; Binding, Competitive; Caffeine; Carbamazepine; Female; Hippocampus; Humans; Male; Middle Aged; Oxcarbazepine; Purinergic Antagonists; Receptors, Purinergic; Xanthines

1993
The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists.
    Pain, 2004, Volume: 111, Issue:3

    Topics: Analgesics, Non-Narcotic; Animals; Caffeine; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Hyperalgesia; Male; Oxcarbazepine; Pain Measurement; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1

2004
Peripheral anti-hyperalgesia by oxcarbazepine: involvement of adenosine A1 receptors.
    Die Pharmazie, 2006, Volume: 61, Issue:6

    Topics: Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Anticonvulsants; Caffeine; Carbamazepine; Dose-Response Relationship, Drug; Drug Synergism; Functional Laterality; Hyperalgesia; Male; Oxcarbazepine; Peripheral Nervous System; Phosphoric Diester Hydrolases; Rats; Rats, Wistar; Receptor, Adenosine A1; Xanthines

2006
Caffeine reverses antinociception by oxcarbazepine by inhibition of adenosine A1 receptors: insights using knockout mice.
    Neuroscience letters, 2010, Apr-12, Volume: 473, Issue:3

    Topics: Adenosine A1 Receptor Antagonists; Analgesics; Animals; Caffeine; Carbamazepine; Drug Antagonism; Female; Male; Mice; Mice, Knockout; Oxcarbazepine; Pain; Pain Measurement; Receptor, Adenosine A1

2010
chemdatabank.com